Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centrus Energy Corp (LEU) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Centrus Energy CorpTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Centrus Energy Corp vs uniQure N.V. Ordinary Shares — how do they compare? Centrus Energy Corp trades at $117.86 (market cap $2.75B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Centrus Energy Corp is the larger of the two by market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Centrus Energy Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Centrus Energy Corp for 31 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

LEUQURE
Market Cap
$2.75B$1.48B
Volume
573,0412,488,780
Sector
EnergyHealth
52-Week High
$436.00$70.59
52-Week Low
$119.95$9.03
Typical Hold Time
31 Days0 Days
Enterprise Value
$2.06B$728.62M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centrus Energy Corp

Centrus Energy (LEU) trades at $134.28, down 0.76% on the day, with technical indicators showing a bearish trend. The company maintains strong fundamentals with $448.70M revenue and $77.80M net income for 2025, though profitability declined in 2026. Recent multi-year HALEU supply contracts with Antares and Radiant highlight Centrus' strategic position in the nuclear fuel market as the only US-licensed HALEU producer.

The stock presents a compelling growth opportunity in nuclear energy infrastructure with 46% analyst buy ratings and $218.10 consensus price target, but faces execution risks amid high valuation multiples (P/E 71.05) and recent earnings volatility. Key risks include dependency on nuclear policy support and competitive pressures in uranium enrichment.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LEU
11% Buy89% Sell
Avg holding period · 31 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Centrus Energy Corp

Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.

Read more on LEU →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →